Загрузка...
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations
Objective: To evaluate the efficacy and tolerability of anti-tumour necrosis factor α (TNFα) monoclonal antibody (infliximab) in the treatment of spondyloarthropathy (SpA) associated with active and inactive Crohn's disease (CD). Methods: Twenty four patients with SpA associated with active or...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2004
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1754868/ https://ncbi.nlm.nih.gov/pubmed/15297279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.012450 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|